ZYDUSLIFE — Zydus Lifesciences Share News
0.000.00%
- IN₹1.19tn
- IN₹1.30tn
- IN₹271.48bn
Brief: Zydus Lifesciences And Sterling Biotech Extend API Business Acquisition Closing To June 30
Focus: Lilly, Novo lock horns in India's obesity drug race
Brief: Zydus Lifesciences Partners With Bioeq For U.S. Rights To NUFYMCO
Brief: Zydus Lifesciences Signs Agreement With Myriad Genetics For Cancer-Risk Tests In India
Brief: Zydus Lifesciences Says FDA Accepts Sentynl's Cutx-101 NDA Resubmission
Brief: Zydus Lifesciences Launches Biosimilar Denosumab 120 Mg SC
Brief: Formycon And Zydus Partner For Exclusive Licensing And Supply Agreement Of Fyb206
Brief: Formycon and Zydus Partner For Exclusive Licensing And Supply Agreement Of FYB206
Brief: Zydus Lifesciences Receives EIR For Injectable Facility Located At Jarod
Brief: Zydus Lifesciences Receives Tentative Approval From USFDA For Empagliflozin And Linagliptin Tablets
Brief: Zydus Lifesciences and RK Pharma Enter Into Exclusive Licensing And Commercialization Agreement
Brief: Zydus Lifesciences Receives Final Approval From USFDA For Verapamil Hydrochloride Extended-Release Tablets
Brief: Zydus Lifesciences Leuprolide Acetate To Be Manufactured At Sez1, Ahmedabad
Brief: Zydus Lifesciences Receives Final Approval From USFDA For Leuprolide Acetate Injection
Brief: Zydus Lifesciences - Closure Of USFDA Inspection At Zydus' Oncology Injectable Manufacturing Facility In Sez1, Ahmedabad
Brief: Zydus Lifesciences Gets Final Approval From USFDA For Diroximel Fumarate Delayed-Release Capsules
Brief: Zydus Lifesciences Approval From China’S Nmpa For Venlafaxine Extended-Release Capsules
Brief: Zydus Lifesciences To Raise Up To 50 Billion Rupees
Brief: Zydus Lifesciences Sept-Quarter Consol Net Profit 12.59 Billion Rupees